Coronavirus Update: Gilead's Veklury Gets Full FDA Approval, Roche Partners With Atea
Moderna Fully Enrolls COVE Trial
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
